Reflecting on the clinical implications, St-Pierre says that the findings support cautious use of GLP-1 RAs in selected patients with IBD when prescribed for approved metabolic indications, with appropriate counselling and monitoring. At the same time, she noted that the findings highlight substantial evidence gaps and believes future research should move beyond proxy outcomes and incorporate prospective, IBD-specific designs that integrate objective inflammatory measures with robust metabolic phenotyping. Moreover, there should be special considerations on the effects of GLP-1 RAs on body composition of patients with IBD, she adds
Micronutrient IV therapy has a variety of uses, from energy and immune-boosting to detoxification and age management and even weight loss
In this systematic review, authors systematically analyzed existing literature on using GLP-1RAs in managing binge eating behaviors
Prevalence, diagnosis, and treatment with 3 different statins of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in military personnel
Q: Is this suitable for sensitive skin
This study investigates the effects of Bifidobacterium, isolated from skin microbiota, on glucagon-like peptide-1 (GLP-1) production, with implications for alleviating various human ailments